Literature DB >> 12871522

Eptifibatide-induced thrombocytopenia and coronary bypass operation.

K A Tanaka, J D Vega, A B Kelly, S R Hanson, J H Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12871522     DOI： 10.1046/j.1538-7836.2003.00056.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  6 in total

Review 1.  Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment.

Authors:  S M Said; J Hahn; E Schleyer; M Müller; G M Fiedler; M Buerke; R Prondzinsky
Journal:  Clin Res Cardiol       Date:  2006-12-08       Impact factor: 5.460

Review 2.  Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty.

Authors:  Michael W Tempelhof; Keith H Benzuly; Dan Fintel; Marc Z Krichavsky
Journal:  Tex Heart Inst J       Date:  2012

3.  Eptifibatide-induced thrombocytopenia and thrombosis.

Authors:  Slava Epelman; Deepu Nair; Ross Downey; Mike Militello; Arman T Askari
Journal:  J Thromb Thrombolysis       Date:  2006-10       Impact factor: 2.300

4.  Eptifibatide-induced thrombocytopenia.

Authors:  Marwan Refaat; A J Conrad Smith; Daniel Edmundowicz
Journal:  J Thromb Thrombolysis       Date:  2007-11-16       Impact factor: 2.300

5.  Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.

Authors:  Cunji Gao; Brian Boylan; Dan Bougie; Joan C Gill; Jessica Birenbaum; Debra K Newman; Richard H Aster; Peter J Newman
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

6.  Acute Severe Thrombocytopenia Occurring After Administration of Eptifibatide Postpones Emergent Coronary Artery Surgery.

Authors:  Brent T Boettcher; Timothy J Olund; Paul S Pagel
Journal:  Anesth Pain Med       Date:  2016-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.